Skip to content

An Open Single Arm Single Centric Clinical Trail To Evaluate The Effectiveness Of Internal medicine Seenthil Chooranam And External medicine Pancharathina Kalimbu In The Management Of Puzhuvettu (Alopecia Areata)

An Open, Single Arm , Single Centric Clinical Trial To Evaluate The Effectiveness Of Internal medicine Seenthil Chooranam And External medicine Pancharathina Kalimbu In The Management Of Puzhuvettu (Alopecia Areata)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/058033
Enrollment
10
Registered
2023-09-26
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: Seenthil chooranam (internal) and Pancha rathina kalimbu (external): Internal 19.6g Seenthil chooranam will be dispensed in air tight container once in 7 days for 48 days External 10g o

Sponsors

National Instiyute Of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Presence of hairloss in well circumscribed patches Patients with the SALT score of S 1 – S 3 Willing to take photograph of the Alopecia lesion Willing to participate in trial and signing consent by fulfilling the condition of Proforma

Exclusion criteria

Exclusion criteria: Hair loss with any signs of inflammation dandruff like scaling from the scalp History of Alopecia with no evidence of hair regrowth for above 10 years Scarring alopecia Alopecia universalis Alopecia totalis vitiligo seborrhoic dermatitis cicatricial alopecia Pregnant and lactating mothers Hypothyroidism malignancy systemic infections

Design outcomes

Primary

MeasureTime frame
The therapeutic effectiveness of Seenthil chooranam internal and Pancha Rathina Kalimbu external in the management of Puzhuvettu Alopecia Areata will be determined and the quantitative assessment of scalp hair loss will be monitored by using SALT SCORETimepoint: 2 MONTHS SCREENING 2 MONTHS PATIENT ENROLLMENT 2 MONTHS OUTCOME ASSESSMENT

Secondary

MeasureTime frame
The quality of life in Alopecia Areata patients using Becks Depression Inventory will be determined.Timepoint: 2 MONTHS SCREENING 2 MONTHS PATIENT ENROLLMENT 2 MONTHS OUTCOME ASSESSMENT

Countries

India

Contacts

Public ContactDrCilfa

National Institute Of Siddha

dr.vetha@gmail.com9894782366

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026